References
Auterhoff H, Scherff FC (1960) Die Dianthrone der pharmazeutisch interessierenden Hydroxyanthrachinone. Arch Pharm (Weinheim) 293:918–925
Brockmann H, Neef R, Mühlmann E (1950) Zur Synthese hypericin-ähnlicher Oxy-naphthodianthrone. Chem Ber 83:467–484
Hillenkamp F (1983) Laser-induced ion formation from organic solids. Springer Ser Chem Phys 25:190–205
Kiistala U, Mustakallio KK (1964) In vivo separation of epidermis by production of suction blisters. Lancet 1:1444–1445
Runne U, Kunze J (1982) Short-duration (“minutes”) therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol 106:135–139
Runne U, Rosmarinowski J, Safar GJ, Kupka KD, Schultz-Amling W, Plumier E, Wiegrebe W (1983) Demonstration of dithranol in normal and psoriatic skin with laser-microprobe mass analysis (LAMMA) and biochemical techniques. Measurement methods for the in vivo penetration and metabolization. Arch Dermatol Res 275:269–270
Sa e Melo T, Dubertret L, Prognon P, Gond A, Mahuzier G, Sautus R (1983) Physiochemical properties and stability of anthralin in model systems and human skin. Invest Dermatol 80:1–6
Van Duuren BL, Segal A, Tseng S-S, Rusch GM, Loewengart UM, Roth D, Smith A, Melchionne S, Seidman J (1978) Structure and tumor-promoting activity of analogues of anthralin. J Med Chem 21:26–31
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wiegrebe, W., Plumier, E., Mayer, K.K. et al. Experimental contribution to the dithranol-brown problem. Arch Dermatol Res 277, 153–155 (1985). https://doi.org/10.1007/BF00414118
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00414118